Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjresp-2016-000148
PubMed Identifier: 28074135
Publication URI: http://europepmc.org/abstract/MED/28074135
Type: Journal Article/Review
Parent Publication: BMJ Open Respiratory Research
Issue: 1
ISSN: 2052-4439